TenenbaumA, FismanEZ, MotroM. Metabolic syndrome and type 2 diabetes mellitus: Focus on Peroxisome Proliferator Activated Receptors (PPAR). Cardiovasc Diabetol, 2003; 2(1):4; doi: 10.1186/1475-2840-2-4
2.
WilsonPWF, D’AgostinoRB, PariseH, et al.Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation, 2005; 112(20):3066–3072; doi: 10.1161/circulationaha.105.539528
3.
OrmazabalV, NairS, ElfekyO, et al.Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol, 2018; 17(1):122; doi: 10.1186/s12933-018-0762-4
4.
SzablewskiL. Insulin resistance: The increased risk of cancers. Curr Oncol, 2024; 31(2):998–1027; doi: 10.3390/curroncol31020075
5.
MàrmolJM, CarlssonM, RaunSH, et al.Insulin resistance in patients with cancer: A systematic review and meta-analysis. Acta Oncol, 2023; 62(4):364–371; doi: 10.1080/0284186x.2023.2197124
6.
SchiancaGPC, CastelloL, RapettiR, et al.Insulin sensitivity: Gender-related differences in subjects with normal glucose tolerance. Nutr Metab Cardiovasc Dis, 2006; 16(5):339–344; doi: 10.1016/j.numecd.2005.05.004
7.
CareyDG, JenkinsAB, CampbellLV, et al.Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes, 1996; 45(5):633–638; doi: 10.2337/diab.45.5.633
8.
JanssenI, PowellLH, CrawfordS, et al.Menopause and the metabolic syndrome the study of women’s health across the nation. Arch Intern Med, 2008; 168(14):1568–1575; doi: 10.1001/archinte.168.14.1568
9.
De PaoliM, ZakhariaA, WerstuckGH. The role of estrogen in insulin resistance. Am J Pathol, 2021; 191(9):1490–1498; doi: 10.1016/j.ajpath.2021.05.011
10.
GordonT, KannelWB, HjortlandMC, et al.Menopause and coronary heart disease: The Framingham study. Ann Intern Med, 1978; 89(2):157–161; doi: 10.7326/0003-4819-89-2-157
11.
BadawyY, SpectorA, LiZ, et al.The risk of depression in the menopausal stages: A systematic review and meta-analysis. J Affect Disord, 2024; 357:126–133; doi: 10.1016/j.jad.2024.04.041
12.
EskolaPJ, JokelainenJ, JärvelinMR, et al.Depression and insulin resistance: Additional support for the novel heuristic model in perimenopausal depression. Am J Psychiatry, 2015; 172(8):796–797; doi: 10.1176/appi.ajp.2015.15030377
13.
KaufertPA. Women and their health in the middle years: A Manitoba project. Soc Sci Med, 1984; 18(3):279–281; doi: 10.1016/0277-9536(84)90091-1
14.
McKinlayJB, McKinlaySM, BrambillaDJ. Health status and utilization behavior associated with menopause. Am J Epidemiol, 1987; 125(1):110–121; doi: 10.1093/oxfordjournals.aje.a114492
15.
MatthewsKA, MeilahnE, KullerLH, et al.Menopause and risk factors for coronary heart disease. N Engl J Med, 1989; 321(10):641–646; doi: 10.1056/nejm198909073211004
16.
El KhoudarySR, GreendaleG, CrawfordSL, et al.The menopause transition and women’s health at midlife: A progress report from the Study of Women’s Health across the Nation (SWAN). Menopause, 2019; 26(10):1213–1227; doi: 10.1097/GME.0000000000001424
17.
ChenY, BrooksMM, El KhoudarySR, et al.Association between depressive symptoms and insulin resistance and the impact of the menopausal transition. J Women’s Health, 2026; 35(2):152–162; doi: 10.1177/15409996251379406
18.
WallaceTM, LevyJC, MatthewsDR. Use and abuse of HOMA modeling. Diabetes Care, 2004; 27(6):1487–1495; doi: 10.2337/diacare.27.6.1487
19.
MonnierL, ColetteC, DunseathGJ, et al.The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care, 2007; 30(2):263–269; doi: 10.2337/dc06-1612
20.
KulkarniJ, GavrilidisE, HudaibAR, et al.Development and validation of a new rating scale for perimenopausal depression—the Meno-D. Transl Psychiatry, 2018; 8(1):123; doi: 10.1038/s41398-018-0172-0
21.
HarlowSD, GassM, HallJE, et al.; STRAW 10 Collaborative Group. Executive summary of the stages of reproductive aging workshop + 10: Addressing the unfinished agenda of staging reproductive aging. Menopause, 2012; 19(4):387–395; doi: 10.1097/gme.0b013e31824d8f40
22.
SwansonLM, HoodMM, HallMH, et al.Sleep timing, sleep regularity, and psychological health in early late life women: Findings from the Study of Women’s Health Across the Nation (SWAN). Sleep Health, 2023; 9(2):203–210; doi: 10.1016/j.sleh.2022.11.001
23.
HallMH, OkunML, SowersM, et al.Sleep is associated with the metabolic syndrome in a multi-ethnic cohort of midlife women: The SWAN sleep study. Sleep, 2012; 35(6):783–790; doi: 10.5665/sleep.1874
24.
TaylorBJ, MatthewsKA, HaslerBP, et al.Bedtime variability and metabolic health in midlife women: The SWAN sleep study. Sleep, 2016; 39(2):457–465; doi: 10.5665/sleep.5464
25.
MattaJ, HoertelN, Kesse-GuyotE, et al.Diet and physical activity in the association between depression and metabolic syndrome: Constances study. J Affect Disord, 2019; 244:25–32; doi: 10.1016/j.jad.2018.09.072
